10 results match your criteria cancer 3 years

  • Page 1 of 1

Retroperitoneal Laparoscopic Radical Prostatectomy.

Chirurgia (Bucur) 2018 Jul-Aug;113(4):542-550

Retroperitoneal Laparoscopic Radical Prostatectomy (RLRP) has been introduced in our department as the first line treatment for patients with localized prostatic cancer and life expectancy over 10 years. At the time, the surgical team had already extensive experience in minimally invasive urologic surgery. Our aim is to describe the laparoscopic technique we currently use and to analyze our oncologic and functional results. Read More

View Article and Full-Text PDF

Late-onset hypogonadism and mortality in aging men.

J Clin Endocrinol Metab 2014 Apr 11;99(4):1357-66. Epub 2013 Dec 11.

Andrology Research Unit (S.R.P., J.D.F., F.C.W.W.) and Manchester Diabetes Centre (M.K.R.), The University of Manchester, and Arthritis Research UK Epidemiology Unit (S.R.P., D.M.L., T.W.O., A.T.), Manchester Academic Health Science Centre, The University of Manchester, Manchester M13 9WL, United Kingdom; Department of Surgery and Cancer (I.T.H.), Imperial College London, Hammersmith Campus, London W12 ONN, United Kingdom; Department of Obstetrics, Gynaecology, and Andrology (G.B.), Albert Szent-György Medical University, H-6721 Szeged, Hungary; Departments of Geriatric Medicine (S.B.) and Andrology and Endocrinology (D.V.), Catholic University of Leuven, Leuven B-3000, Belgium; Department of Medicine (F.F.C.), Santiago de Compostela University, Complejo Hospitalario Universitario de Santiago, and Centro de Investigación Biomédica en Red de Fisiopatologia Obesidad y Nutricion (CB06/03), Instituto Salud Carlos III, 15705 Santiago de Compostela, Spain; Endocrinology Unit (G.F.), Department of Clinical Physiopathology, University of Florence, 50121 Florence, Italy; Reproductive Medicine Centre (A.G.), Skåne University Hospital, University of Lund, SE-22 184 Lund, Sweden; Department of Endocrinology (T.S.H.), University College London, London W1T 3AA, United Kingdom; Department of Andrology and Reproductive Endocrinology (K.K.), Medical University of Łódź, 90-419 Łódź, Poland; Department of Human Nutrition (M.E.L.), University of Glasgow, Glasgow G12 8TA, United Kingdom; School of Community-Based Medicine (N.P.), University of Manchester, Salford Royal National Health Service Trust, Salford M6 8HD, United Kingdom; and Andrology Unit (M.P.), United Laboratories of Tartu University Clinics, 51014 Tartu, Estonia.

Context: Late-onset hypogonadism (LOH) has recently been defined as a syndrome in middle-aged and elderly men reporting sexual symptoms in the presence of low T. The natural history of LOH, especially its relationship to mortality, is currently unknown.

Objective: The aim of this study was to clarify the associations between LOH, low T, and sexual symptoms with mortality in men. Read More

View Article and Full-Text PDF

One hundred years of lung cancer.

Am J Respir Crit Care Med 2005 Sep 16;172(5):523-9. Epub 2005 Jun 16.

Department of Thoracic Medicine, Middlesex Hospital, Mortimer Street, London WIT 3AA, UK.

A hundred years ago, lung cancer was a reportable disease, and it is now the commonest cause of death from cancer in both men and women in the developed world, and before long, will reach that level in the developing world as well. The disease has no particular symptoms or signs for its detection at an early stage. Most patients therefore present with advanced stage IIIB or IV disease. Read More

View Article and Full-Text PDF
September 2005

Impact of combined (18)F-FDG PET/CT in head and neck tumours.

Br J Cancer 2005 Mar;92(6):1046-50

Institute of Nuclear Medicine, Middlesex Hospital, Mortimer Street, London W1N 3AA, UK.

To compare the interobserver agreement and degree of confidence in anatomical localisation of lesions using 2-[fluorine-18]fluoro-2-deoxy-D-glucose ((18)F-FDG) positron emission tomography (PET)/computed tomography (CT) and (18)F-FDG PET alone in patients with head and neck tumours. A prospective study of 24 patients (16 male, eight female, median age 59 years) with head and neck tumours was undertaken. (18)F-FDG PET/CT was performed for staging purposes. Read More

View Article and Full-Text PDF

Radiofrequency ablation of colorectal liver metastases.

Abdom Imaging 2005 Jul-Aug;30(4):419-26

Department of Medical Imaging, The Middlesex Hospital, Mortimer Street, London W1T 3AA, United Kingdom.

Background: Untreated patients with colorectal liver metastases rarely survive 3 years, and the 3-year survival rate for patients treated with chemotherapy is 3%. The best survival rates are for the small subgroup that has operable disease, i.e. Read More

View Article and Full-Text PDF
December 2005

Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.

Abdom Imaging 2005 Jul-Aug;30(4):435-41

Department of Medical Imaging, The Middlesex Hospital, Mortimer Street, London W1T 3AA, United Kingdom.

Background: Current treatment options for neuroendocrine liver metastases are not widely applicable or not that effective. Image-guided thermal ablation offers the possibility of a minimally invasive, albeit palliative, treatment that decreases tumor volume, preserves most of the normal liver, and can be repeated several times. We report our experience with image-guided thermal ablation in 25 patients with unresectable liver metastases. Read More

View Article and Full-Text PDF
December 2005

How often do patients undergo repeat PET or PET/CT examinations? Experience from a UK institution.

Nucl Med Commun 2005 Feb;26(2):137-9

Institute of Nuclear Medicine, University College London, Middlesex Hospital, London W1T 3AA, UK.

Background And Aim: According to the report of the Intercollegiate Standing Committee on Nuclear Medicine, the UK requires 40-60 positron emission tomography (PET) machines in the next decade (Intercollegiate Standing Committee on Nuclear Medicine). Positron Emission Tomography: a Strategy for Provision in the UK. London: Royal College of Physicians of London; 2003, pp. Read More

View Article and Full-Text PDF
February 2005

Radio-frequency ablation of colorectal liver metastases in 167 patients.

Eur Radiol 2004 Dec 27;14(12):2261-7. Epub 2004 Jul 27.

Department of Medical Imaging, The Middlesex Hospital, Mortimer Street, London W1T 3AA, UK.

The objective of this paper is to report our results from a prospective study of 167 patients with colorectal liver metastases treated with radio-frequency ablation (RFA). Three hundred fifty-four treatments were performed in 167 patients, 99 males, mean age 57 years (34-87). The mean number of metastases was 4. Read More

View Article and Full-Text PDF
December 2004

Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women.

Jeffrey S Tobias

Int J Biochem Cell Biol 2004 Nov;36(11):2112-9

Meyerstein Institute of Clinical Oncology, Middlesex Hospital, London W1T 3AA, UK.

Preventing clinical progression is the major treatment goal for both early and advanced breast cancer. For hormone-responsive cases (about 70% of the total), this can necessitate the use of sequential hormone therapies at various points during the patient's life. Newer hormonal therapies, such as the third-generation aromatase inhibitor anastrozole, are now competing with tamoxifen as first choice endocrine therapy in breast cancer. Read More

View Article and Full-Text PDF
November 2004

Where should teenagers with cancer be treated?

J Whelan

Eur J Cancer 2003 Dec;39(18):2573-8

The Middlesex Hospital, UCL Hospitals NHS Trust, Mortimer Street, London W1T 3AA, UK.

Cancer in teenagers is relatively uncommon. Few health professionals in oncology are familiar with caring for teenagers, although most would acknowledge them as a characterisable clientele with specific needs different to those of others with cancer, whether younger or older. Many of those diagnosed with cancer between 13 and 20 years of age will be cured, often after intensive, toxic and life-changing treatment. Read More

View Article and Full-Text PDF
December 2003
  • Page 1 of 1